Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• ‘Just pick up the phone’: The case for cross-specialty coordination in AS, IBD Rob Volansky
• Convalescent plasma reduces hospitalization risk in COVID-19 Erich Martin
• Cyclobenzaprine tablets fail phase 3 trial for fibromyalgia pain Jason Laday
• FDA grants priority review for tocilizumab to treat patients hospitalized with COVID-19 Jason Laday
• Why I love rheumatology: It’s all about inter-professionalism Leonard H. Calabrese, DO
• Sotrovimab no longer authorized to treat COVID-19 in areas with high BA.2 frequency Jason Laday
• A ‘more useful’ drug label: FDA seeks to add immunogenicity section to biologic labels Rob Volansky
• Healio celebrates 10-year anniversary
• New drugs, new guidelines: ACR/AAHKS update treatment recommendations in joint replacement Rob Volansky
• Hooked on Rheum with Stanley Cohen, MD Stanley Cohen, MD
• Axial SpA manifestations, disease activity vary widely across geographic regions Jason Laday
• Children who experience adverse childhood events may have worse chronic pain symptoms Erich Martin
• Deucravacitinib superior to placebo for ACR20 response in psoriatic arthritis Erich Martin
• EULAR: ‘Never too late’ for patients with rheumatic disease to start exercising Erich Martin
• EULAR takes ‘precautionary position’ in support of third, booster COVID-19 vaccine doses Jason Laday
• Older children, those with high ferritin at greater risk for severe MIS-C after COVID-19 Jason Laday
• Only highest-dose iberdomide outperforms placebo in SLE; adverse events high Jason Laday
• Osteoarthritis prevalence increased more than 113% globally from 1990-2019 Erich Martin
• Patients with gut dysbiosis show worse axial SpA disease activity, physical function Jason Laday
• Racial inequities remain in pediatric lupus care despite overall outcome improvements Erich Martin
• Rheumatoid arthritis-related autoimmunity alone does not increase cardiovascular risk Erich Martin
• Social media may highlight research needs, clinical care gaps in lupus Erich Martin
• Surge in specialty drug use ‘largely driven’ by autoimmune disease Jason Laday
• Accentuate the negative: ‘Loss framing’ improves habits in osteoarthritis over positivity Rob Volansky
• ‘Disturbance and breakdown’ of cartilage holds clues to biomarkers in osteoarthritis Rob Volansky
• Gut microbiota dysbiosis may shed light on synovial abnormality in hand osteoarthritis Rob Volansky
• ‘Statistically significant but small’: Exercise may improve fatigue in osteoarthritis Rob Volansky
• TPX-100 injection may ‘reduce or eliminate’ need for knee replacement in osteoarthritis Rob Volansky
• Walking, maximum-level activity reduce odds of cartilage loss in knee osteoarthritis Rob Volansky
• Wearable devices reliable in assessing gait, chair stand speed at home in osteoarthritis Rob Volansky
• Women, overweight patients with osteoarthritis most likely to report poor pain relief Rob Volansky
• Q&A: CD6/ALCAM may hold key to more specific, effective therapies in lupus nephritis Rob Volansky